Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD.
Recruiting · NCT05922202 · Observational (researchers observe without assigning treatment) · Lead sponsor: Azienda Ospedaliero-Universitaria di Modena
View the official record on ClinicalTrials.gov →Interventions studied
Assessment of cardiovascular events, cardiovascular mortality, all-cause mortality, and mortality due to COPD at 12 and 24 months
What this trial is about
Observational study on the influence of frailty on cardiovascular risk in COPD.
Who can take part
Age range
40 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with age ≥18 years, with diagnosis of COPD of at least 1 year, in stable condition, without acute exacerbation in the last 30 days and/or all-cause hospitalisation in the last 3 months
- Smoking history of ≥ 10 pack/years
- Diagnosis of COPD according to GOLD guidelines (www.goldcopd.org)
- Individuals able to provide their written informed consent.
Exclusion criteria
- Concurrent diagnosis of interstitial lung disease
- Presence of restrictive pattern on spirometry
- No history of smoking habit
- Individuals not able to provide their written informed consent.
Where it is running
1 location listed.
- Respiratory Unit - Hospital Policlinico Modena - Modena, Italy